Serum growth hormone and somatomedin-C in patients with bilharzial hepatic fibrosis and post hepatitic cirrhosis.

Twenty patients with bilharzial periportal fibrosis, 20 patients with post hepatitic cirrhosis and 20 normal controls were chosen for assessment of serum level of human growth hormone (HGH) before and after insulin induced hypoglycemia and Somatomedin-C (Sm-C). In the first group no statistical significant difference was noticed in HGH before and after insulin test but the basal serum level of Sm-C showed a statistically significant decrease after insulin test. In the second group HGH showed statistical significant increase before and after insulin induced hypoglycemia. Also, the mean serum level of Sm-C showed a statistical significant decrease before and after insulin induced hypoglycemia.